Nine students from Chassell High School know how an atomic force microscope works. In fact, they've built a model of one out of Lego bricks. They're the members of INANO (Identifying New Academic Nanotechnology Opportunities), Chassell High School's Enterprise team.
Image sensors as used in cell phones are partially color-blind. This is because of their coating, which prevents UV light from passing through. CMOS chips have as a result not been suitable for spectroscopy up to now. A new production process makes the coating transparent - and the sensors suitable for special applications.
The electronic chips of the future might not be made of silicon or even graphene but of a material called molybdenite (MoS2). EU-funded research presented in the journal Nature Nanotechnology demonstrates that molybdenite is a highly effective semi-conductor that could be used to make transistors both smaller and more energy efficient.
The Centre for Environmental Law Decisions and Corporate Ethical Certification (CIGA) at the University of Padua and the Institute for Technology Assessment and Systems Analysis (ITAS) at the Karlsruhe Institute of Technology, organize an international workshop titled Dilemmas of choice. Responsibility in nanotechnology development, which is aimed at presenting and debating contributions from different disciplines on several issues concerning the relationship between nanotechnology innovation and responsibility.
The aim of the workshop is to bring together leaders in the emerging field of computational nanotoxicology to form an international Community of Practice for accelerated development of the science of QNTR.
Inspired by the popular confidence trick known as 'shell game', researchers at UC Santa Barbara have demonstrated the ability to hide and shuffle 'quantum-mechanical peas' - microwave single photons - under and between three microwave resonators, or 'quantized shells'.
'Cornell Dots' -- brightly glowing nanoparticles -- may soon be used to light up cancer cells to aid in diagnosing and treating cancer. The U.S. Food and Drug Administration (FDA) has approved the first clinical trial in humans of the new technology.
Researchers at Memorial Sloan-Kettering Cancer Center's Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies, have received approval for their first Investigational New Drug Application (IND) from the US Food and Drug Administration (FDA) for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future.
The next big thing in medical diagnostics could be minutes particles of rust, iron oxide, coated with the material from which sand is formed, silicon dioxide. These magnetic nanoparticles, a mere 29 to 230 nanometers across, can be used to trap antibodies to the virus that causes cervical cancer and to the bacteria that causes potentially lethal diarrhea.